----

----

| (Mark      one)                                                   |
|-------------------------------------------------------------------|
| x                                                                 | ANNUAL      REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934 |
| For      the fiscal year ended December 31, 2007                  |
|                                                              |   |
| o                                                                 | TRANSITION      REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934 |
| For      the transition period from ___________ to  _____________ |

| California                                                              | 95-3280412                                   |
|-------------------------------------------------------------------------|----------------------------------------------|
| (State      or other jurisdiction ofincorporation      or organization) | (I.R.S.      Employer Identification Number) |

| 15350      Sherman Way, Suite 350             |                  |
|-----------------------------------------------|-----------------------|
| Van      Nuys, California                     |  91406           |
| (Address      of principal executive offices) |  (Zip      Code) |

| Securities      registered pursuant to Section 12(b) of the Act: | None                                    |
|------------------------------------------------------------------|-----------------------------------------|
| Securities      registered pursuant to Section 12(g) of the Act: | Common      Stock (without par value)   |
|                                                             | Rights      to purchase Preferred Stock |

----

----

EXPLANATORY NOTE

----

|   | a. | Recorded,      processed, summarized and reported within the time period specified in the      Securities and Exchange Commission’s rules and forms;  and |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | b. | Accumulated      and communicated to our management, including our principal executive and      principal financial officer, to allow timely decisions regarding required      disclosure. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | · | Potential impact on the accuracy      of the financial statements(30%) |
|--------|--------|------------------------------------------------------------------------|

|   | · | Nature and complexity      (20%) |
|--------|--------|----------------------------------|

|   | · | Degree of subjectivity      (20%) |
|--------|--------|-----------------------------------|

|   | · | Potential for fraud      (20%) |
|--------|--------|--------------------------------|

|   | · | Previously identified errors      (10%) |
|--------|--------|-----------------------------------------|

Reporting

efforts to address the materialweakness in its internal controlover financial reporting.  Specific actions which have been or will betaken are outlined below:

----

|   | · | developed      a list of identified controlweaknesses; |
|--------|--------|--------------------------------------------------------|

|   | · | developed      action plans to correct each identified  weakness; |
|--------|--------|-------------------------------------------------------------------|

|   | · | held      meetings to discuss the allocation of resources and timelines to complete      each action plan; |
|--------|--------|------------------------------------------------------------------------------------------------------------|

|   | · | instituted      other mitigating controls over revenue recognition and over the use of      spreadsheets to enhance the control environment pertaining to these areas      of material weakness; and |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | · | evaluated      and standardized SOX testing andcontrols. |
|--------|--------|----------------------------------------------------------|

|   | · | evaluate      accounting and control systems to identify opportunities for enhanced      controls; |
|--------|--------|----------------------------------------------------------------------------------------------------|

|   | · | recruit      and hire additional staff to provide greater segregation of      duty; |
|--------|--------|-------------------------------------------------------------------------------------|

|   | · | evaluate      the need for other employeechanges; |
|--------|--------|---------------------------------------------------|

|   | · | expand      executive management's ongoing communications regarding the importance of      adherence to internal controls and company  policies; |
|--------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------|

|   | · | implement      an internal auditing function at HemaCare and its subsidiaries;      and |
|--------|--------|-----------------------------------------------------------------------------------------|

|   | · | evaluate      such other actions as the Company’s advisors may  recommend. |
|--------|--------|----------------------------------------------------------------------------------|

|   | 2.1 | Stock      Purchase Agreement dated August 29, 2006, among HemaCare Corporation,      Joseph Mauro, Valentin Adia and Teragenix Corporation, incorporated by      reference to Exhibit 99.1 to Form 8-K of the Registrant filed on September      5, 2006. |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2.2 | Amendment      to Stock Purchase Agreement, dated as of November 14, 2006, among HemaCare      Corporation, Joseph Mauro, Valentin Adia and Teragenix Corporation,      incorporated by reference to Exhibit 99.12 to Amendment No. 1 to Form 8-K      of the Registrant filed on November 15,2006. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3.1 | Restated      Articles of Incorporation of the Registrant, incorporated by reference to      Exhibit 3.1 to Form 10-K of the Registrant for the year ended December 31,      2002. |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3.2 | Amended      and Restated Bylaws of the Registrant, as amended, incorporated by      reference to Exhibit 3.1 to Form 8-K of the Registrant filed on March 28,      2007. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 4.1 | Rights      Agreement between the Registrant and U.S. Stock Transfer Corporation dated      March 3, 1998, incorporated by reference to Exhibit 4 to Form 8-K of the      Registrant dated March 5, 1998. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 4.2 | Form      of Common Stock Certificate, incorporated by reference to Exhibit 4.4 to      Form S-8 of the Registrant dated July 10,2006. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.1* | 1996      Stock Incentive Plan, as amended, of the Registrant, incorporated by      reference to Appendix to the Proxy Statement of the Registrant filed on      April 14, 2005. |
|--------|-------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | 10.2* | 2006      Equity Incentive Plan of the Registrant, incorporated by reference to      Annex A to the Proxy Statement of the Registrant filed on April 21,      2006. |
|--------|-------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.3* | 2004      Stock Purchase Plan of the Registrant, incorporated by reference to      Exhibit 10.2 to Form 10-K of the Registrant for the year ended December      31, 2004. |
|--------|-------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.4 | Loan      and Security Agreement between the Registrant, Coral Blood Services, Inc.      and Comerica Bank dated November 19, 2002, incorporated by reference to      Exhibit 10.2 to Form 10-K of the Registrant for the year ended December      31, 2002. |
|--------|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.5 | First      Modification to Loan and Security Agreement between the Registrant, Coral      Blood Services, Inc. and Comerica Bank dated March 22, 2004, incorporated      by reference to Exhibit 10.1 of Form 10-Q of the Registrant for the      quarter-ended March 31, 2004. |
|--------|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.6 | Second      Modification to Loan and Security Agreement between the Registrant, Coral      Blood Services, Inc. and Comerica Bank dated July 1, 2005, incorporated by      reference to Exhibit 10.1 of Form 8-K of the Registrant dated July 1,      2005. |
|--------|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.7 | Third      Modification to Loan and Security Agreement between the Registrant, Coral      Blood Services, Inc. and Comerica Bank dated January 31, 2006,      incorporated by reference to Exhibit 99.1 of Form 8-K of the Registrant      filed on February 3, 2006. |
|--------|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.8 | Lease      agreement between HemaCare Corporation, as tenant, and ECI Sherman      Plaza LLC, as landlord for approximately 20,000 square feet located in Van      Nuys, California, dated February 10, 2006, incorporated by reference to      Exhibit 99.1 of Form 8-K of the Registrant filed on March 1,      2006. |
|--------|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.9 | Amended      and Restated Loan and Security Agreement among HemaCare Corporation, Coral      Blood Services, Inc. and HemaCare BioScience, Inc. and Comerica Bank dated      September 26, 2006, incorporated by reference to Exhibit 99.1 to Form 8-K      of the Registrant filed on September 29,2006. |
|--------|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.9.1 | First      Modification to Amended and Restated Loan and Security Agreement among      HemaCare Corporation, Coral Blood Services, Inc., HemaCare BioScience,      Inc. and Comerica Bank, dated March 26, 2007, incorporated by reference to      Exhibit 99.1 to Form 8-K of the Registrant filed on March 28,      2007. |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.10* | Employment      Agreement between the Registrant and Joshua Levy dated March 22, 2000,      incorporated by reference to Exhibit 10.12 of Form 10-K of the Registrant      for the year ended December 31,2000. |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.11* | Employment      Letter between the Registrant and Judi Irving, dated December 6, 2002,      incorporated by reference to Exhibit 10.8 to Form 10-K of the Registrant      for the year ended December 31,2002. |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.12* | Change      of Control Agreement between HemaCare Corporation and Judi Irving,      President and Chief Executive Officer dated June 6, 2005, incorporated by      reference to Exhibit 10.1 to Form 8-K of the Registrant filed on June 10,      2005. |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.13* | Change      of Control Agreement between HemaCare Corporation and Robert Chilton,      Executive Vice President and Chief Financial Officer, dated June 6, 2005,      incorporated by reference to Exhibit 10.2 to Form 8-K of the Registrant      filed on June 10, 2005. |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | 10.14 | Master      Security Lease Agreement between the Registrant and GE Capital Healthcare      Financial Services dated December 26, 2002, incorporated by reference to      Exhibit 10.10 to Form 10-K of the Registrant for the year ended December      31, 2002. |
|--------|-------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.15* | Employment      Letter between the Registrant and Robert S. Chilton, dated October 3,      2003, incorporated by reference to Exhibit 10.1 to Form 10-Q of the      Registrant for the quarter ended September 30,  2003. |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.16* | Indemnification      Agreement between HemaCare Corporation and Judi Irving, President and      Chief Executive Officer dated July 5, 2006, incorporated by reference to      Exhibit 99.1 to Form 8-K of the Registrant filed on July 6,      2006. |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.17* | Indemnification      Agreement between HemaCare Corporation and Robert Chilton, Executive Vice      President and Chief Financial Officer dated July 5, 2006, incorporated by      reference to Exhibit 99.1 to Form 8-K of the Registrant filed on July 6,      2006. |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.18 | Escrow      Agreement dated as of August 29, 2006, among HemaCare Corporation, Joseph      Mauro, Valentin Adia and U.S. Bank, National Association, incorporated by      reference to Exhibit 99.2 to Registrant’s Current Report on Form 8-K filed      on September 5, 2006. |
|--------|-------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.19 | Promissory      Note dated August 29, 2006, in the principal amount of $153,800, of      HemaCare Corporation payable to Joseph Mauro, incorporated by reference to      Exhibit 99.3 to Registrant’s Current Report on Form 8-K filed on September      5, 2006. |
|--------|-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.20 | Promissory      Note dated August 29, 2006, in the principal amount of $46,200, of      HemaCare Corporation payable to Valentin Adia, incorporated by reference      to Exhibit 99.4 to Registrant’s Current Report on Form 8-K filed on      September 5, 2006. |
|--------|-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.21* | Employment      Agreement dated August 29, 2006, between HemaCare Corporation and Joseph      Mauro, incorporated by reference to Exhibit 99.5 to Registrant’s Current      Report on Form 8-K filed on September 5,2006. |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.22* | Employment      Agreement dated August 29, 2006, between HemaCare Corporation and Valentin      Adia, incorporated by reference to Exhibit 99.6 to Registrant’s Current      Report on Form 8-K filed on September 5,2006. |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.23 | Promissory      Note dated August 29, 2006, in the principal amount of $250,000, of      Teragenix Corporation, payable to Dr. Lawrence Feldman, incorporated by      reference to Exhibit 99.7 to Registrant’s Current Report on Form 8-K filed      on September 5, 2006. |
|--------|-------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.24 | Promissory      Note dated August 29, 2006, in the principal amount of $250,000, of      Teragenix Corporation, payable to Dr. Karen Raben, incorporated by      reference to Exhibit 99.8 to Registrant’s Current Report on Form 8-K filed      on September 5, 2006. |
|--------|-------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.25 | Letter      agreement dated August 29, 2006, among HemaCare Corporation, Teragenix      Corporation, Dr. Lawrence Feldman and Dr. Karen Raben, incorporated by      reference to Exhibit 99.9 to Registrant’s Current Report on Form 8-K filed      on September 5, 2006. |
|--------|-------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.26 | Select      Series License Agreement with Prelude Exhibit dated December 29, 2006,      between Information Data Management, Inc. and HemaCare Corporation,      incorporated by reference to Exhibit 99.1 to Registrant’s Current Report      on Form 8-K filed on January 5,2007. |
|--------|-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | 10.27* | First      Amendment to Employment Agreement between HemaCare Corporation and Joshua      Levy, M.D. dated March 31, 2005 incorporated by reference to Exhibit 10.27      to Form 10-K of the Registrant for the year ended December 31, 2006 filed      April 2, 2007. |
|--------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.28 | Employee      Proprietary Information and Inventions Agreement between Teragenix      Corporation and Joseph Mauro dated August 29, 2006, incorporated by      reference to Exhibit 99.1 to Form 8-K of the Registrant filed on November      7, 2007. |
|--------|-------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.29 | Employee      Proprietary Information and Inventions Agreement between Teragenix      Corporation and Valentin Adia dated August 29, 2006, incorporated by      reference to Exhibit 99.2 to Form 8-K of the Registrant filed on November      7, 2007. |
|--------|-------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.30 | Noncompetition      Agreement between Teragenix Corporation and Joseph Mauro dated August 29,      2006, incorporated by reference to Exhibit 99.3 to Form 8-K of the      Registrant filed on November 7,2007. |
|--------|-------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.31 | Noncompetition      Agreement between Teragenix Corporation and Valentin Adia dated August 29,      2006, incorporated by reference to Exhibit 99.4 to Form 8-K of the      Registrant filed on November 7,2007. |
|--------|-------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.32 | Security      Agreement between Teragenix Corporation and Joseph Mauro dated August 29,      2006, incorporated by reference to Exhibit 99.5 to Form 8-K of the      Registrant filed on November 7,2007. |
|--------|-------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.33 | Security      Agreement between Teragenix Corporation and Valentin Adia dated August 29,      2006, incorporated by reference to Exhibit 99.6 to Form 8-K of the      Registrant filed on November 7,2007. |
|--------|-------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.34 | Assignment      for the Benefit of Creditors made as of December 4, 2007, incorporated by      reference to Exhibit 99.1 to Registrants Current Report on Form 8-K filed      on December 14, 2007. |
|--------|-------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.35 | First      Amendment to Lease between HemaCare Corporation as tenant and ECI Sherman      Plaza, Inc. as landlord, dated August 17, 2006, incorporated by reference      to Exhibit 10.35 to Form 10-K of Registrant for the year-ended December      31, 2007. |
|--------|-------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.36 | Second      Amendment to Lease between HemaCare Corporation as tenant and ECI Sherman      Plaza, Inc. as landlord, dated April 11, 2007, incorporated by reference      to Exhibit 10.36 to Form 10-K of Registrant for the year-ended December      31, 2007. |
|--------|-------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.37 | Amendment      and Extension of Rights Agreement dated as of March 3, 1998, between      HemaCare Corporation and Computershare Trust Company, N.A., incorporated      by reference to Exhibit 99.1 to Registrant’s Current Report on Form 8-K      filed on March 24. 2008. |
|--------|-------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.38 | Indemnification      Agreement between HemaCare Corporation and Julian Steffenhagen, executed      March 11, 2008, incorporated by reference to Exhibit 99.1 to Registrant’s      Current Report on Form 8-K filed on March 17,  2008. |
|--------|-------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 10.39 | Credit      and Security Agreement between HemaCare Corporation, Coral Blood Services,      Inc., and Wells Fargo Bank, National Association, dated April 10, 2008,      incorporated by reference to Exhibit 10.39 to Form 10-K of Registrant for      the year-ended December 31, 2007. |
|--------|-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 11. | Computation      of earnings (loss) per common equivalent share, incorporated by reference      to Exhibit 11 to Form 10-K of Registrant for the year-ended December 31,      2007. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | 14. | Code      of Ethics – incorporated by reference to Exhibit 14 to Form 10-K of the      Registrant for the year ended December 31,2004. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------|

|   | 21. | Subsidiaries      of the Registrant, incorporated by reference to Exhibit 21 to Form 10-K of      Registrant for the year-ended December 31,2007. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 23.1 | Consent      of Stonefield Josephson, Inc., Independent Registered Public Accounting      Firm, incorporated by reference to Exhibit 23.1 to Form 10-K of Registrant      for the year-ended December 31,2007. |
|--------|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 23.1.1** | Consent      of Stonefield Josephson, Inc., Independent Registered Public Accounting      Firm. |
|--------|----------|-------------------------------------------------------------------------------------------------|

|   | 24. | Power      of attorney, incorporated by reference to Exhibit 24 to Form 10-K of      Registrant for the year-ended December 31,2007. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------|

|   | 31.1 | Certification      Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, Adopted      Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, incorporated by      reference to Exhibit 31.1 to Form 10-K of Registrant for the year-ended      December 31, 2007. |
|--------|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 31.1.1** | Certification      Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, Adopted      Pursuant to Section 302 of the Sarbanes-Oxley Act of  2002. |
|--------|----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 31.2 | Certification      Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, Adopted      Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, incorporated by      reference to Exhibit 31.2 to Form 10-K of Registrant for the year-ended      December 31, 2007. |
|--------|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 31.2.1** | Certification      Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, Adopted      Pursuant to Section 302 of the Sarbanes-Oxley Act of  2002. |
|--------|----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 32.1 | Certification      Pursuant to 18 U.S.C. 1350, Adopted Pursuant to Section 906 of the      Sarbanes-Oxley Act of 2002, incorporated by reference to Exhibit 32.1 to      Form 10-K of Registrant for the year-ended December 31,    2007. |
|--------|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 32.1.1** | Certification      Pursuant to 18 U.S.C. 1350, Adopted Pursuant to Section 906 of the      Sarbanes-Oxley Act of2002. |
|--------|----------|-----------------------------------------------------------------------------------------------------------------------|

|   | __________________________ |
|--------|----------------------------|

|   | * | Management      contracts and compensatory plans and  arrangements. |
|--------|---|---------------------------------------------------------------------|

|   | ** | Filed      herewith |
|--------|----|---------------------|

----

| Dated: | March      25, 2009 |   | HEMACARE      CORPORATION                                          |
|--------|---------------------|--------|--------------------------------------------------------------------|
|   |                |   |                                                               |
|   |                |   | By:            /s/ Robert S. Chilton |
|   |                |   | Robert      S. Chilton, Chief Financial Officer                    |
|   |                |   |                                                               |

|  Signature                                                                                                                                                                       |  Title                                                                                                                    |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|
|            *                   Julian      L. Steffenhagen    |  Chairman      of the Board and Chief Executive Officer(Principal      Executive Officer)                                 |
|                                                                                                                                                                                       |                                                                                                                                |
|   /s/   Robert      S. Chilton    Robert      S. Chilton                                                                                 |          Executive Vice President and Chief Financial Officer(Principal      Financial and Accounting Officer)  |
|                                                                                                                                                                                       |                                                                                                                                |
|             *            Steven      Gerber                   |   Director                                                                                                           |
|                                                                                                                                                                                       |                                                                                                                                |
|                     *            Teresa      Sligh  |   Director                                                                                                           |
|                                                                                                                                                                                       |                                                                                                                                |
|            *                   Terry      Van Der Tuuk             |    Director                                                                                                          |

----